A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast Cancer
Clinical trial NCT01200212 · TERMINATED
Trial details
- NCT number
- NCT01200212
- Sponsor
- GBG Forschungs GmbH
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2012-10-01
- Enrollment
- 432
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.